BamSEC and AlphaSense Join Forces
Learn More

Acer Therapeutics Inc

Formerly NASDAQ: ACER

Material Contracts Filter

EX-10.5
from 8-K 16 pages Termination Agreement
12/34/56
EX-10.4
from 8-K 3 pages Amendment No. 1 to Unsecured Promissory Note
12/34/56
EX-10.3
from 8-K 51 pages Exclusive License Agreement
12/34/56
EX-10.2
from 8-K 11 pages Security Agreement
12/34/56
EX-10.2
from 10-Q 14 pages Warrant to Purchase Stock Article 1. Exercise
12/34/56
EX-10.1
from 8-K 3 pages Unsecured Promissory Note
12/34/56
EX-10.1
from 8-K 42 pages Securities Purchase Agreement
12/34/56
EX-10.7
from 8-K 8 pages Material contract
12/34/56
EX-10.4
from 8-K 14 pages Warrant to Purchase Stock
12/34/56
EX-10.1
from 8-K 4 pages Extension Agreement
12/34/56
EX-10.1
from 8-K 20 pages Securities Purchase Agreement
12/34/56
EX-10.3
from 8-K 13 pages Warrant to Purchase Stock
12/34/56
EX-10.1
from 8-K 7 pages Employment Agreement
12/34/56
EX-10.8
from 8-K 14 pages Synthetic Royalty Agreement
12/34/56
EX-10.7
from 8-K 31 pages Guarantee and Collateral Agreement Dated as of [ ], 2022 Among Acer Therapeutics Inc., and Each Other Person That Becomes a Party Hereto as a Grantor, Each as a Grantor, and Mam Aardvark, LLC, as Agent Guarantee and Collateral Agreement
12/34/56
EX-10.5
from 8-K 15 pages Acer Therapeutics Inc. Secured Convertible Note Maturity Date: March [___], 2025
12/34/56
EX-10.4
from 8-K 37 pages Acer Therapeutics Inc. Secured Convertible Note Purchase and Security Agreement
12/34/56
EX-10.3
from 8-K 12 pages Warrant to Purchase Stock
12/34/56
EX-10.2
from 8-K 31 pages Guarantee and Collateral Agreement Dated as of March 4, 2022 Among Acer Therapeutics Inc., and Each Other Person That Becomes a Party Hereto as a Grantor, Each as a Grantor, and Swk Funding LLC, as Agent Guarantee and Collateral Agreement
12/34/56
EX-10.30
from 10-K 2 pages Second Amendment
12/34/56